SCHEMBL3551149

SCHEMBL3551149

C1C2CC3CC1CC(C1CC1)(C2)C3

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 4/20 0.40
GRIN3B O60391 4/20 0.40
GRIN1 Q05586 4/20 0.40
GRIN2A Q12879 4/20 0.40
GRIN2B Q13224 4/20 0.40
GRIN2C Q14957 4/20 0.40
GRIN3A Q8TCU5 4/20 0.40
LMNA P02545 2/20 0.40
SLC22A2 O15244 2/20 0.40
SLC47A1 Q96FL8 2/20 0.40
SLC22A1 O15245 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
STAT6 P42226 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
POLB P06746 1/20 0.38
THRB P10828 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15922722 0.88 GRIN2D (0.36) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL31493486 0.86
SCHEMBL294644 0.85 EPHX1 (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL15922703 0.85 EPHX1 (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22193941 0.81 PKM (0.31) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL17347039 0.81 GRIN2D (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL24559478 0.77 FPR1 (0.34) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL18841473 0.76 SLC22A2 (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22193940 0.73
SCHEMBL31366244 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114437837-B Fuel composition and application thereof 中国石油化工股份有限公司 2023-11-10 CN disclosed
CN-114437837-A Fuel composition and application thereof 中国石油化工股份有限公司 2022-05-06 CN disclosed
US-11203726-B1 Diamondoid fuels THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2021-12-21 US disclosed
US-11118124-B1 Diamondoid fuels THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2021-09-14 US disclosed
US-10710941-B1 Diamondoid fuels THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2020-07-14 US disclosed
US-7855241-B2 Method of improving abrasion resistance of plastic article using nanoparticles and article produced thereby SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-12-21 US disclosed
EP-1945695-A2 METHOD OF IMPROVING ABRASION RESISTANCE OF PLASTIC ARTICLE USING NANOPARTICLES AND ARTICLE PRODUCED THEREBY General Electric Company (US) 2008-07-23 EP disclosed
WO-2007047294-A2 METHOD OF IMPROVING ABRASION RESISTANCE OF PLASTIC ARTICLE USING NANOPARTICLES AND ARTICLE PRODUCED THEREBY GENERAL ELECTRIC COMPANY (US) 2007-04-26 WO disclosed
US-20070088095-A1 Method of improving abrasion resistance of plastic article using nanoparticles and article produced thereby GENERAL ELECTRIC COMPANY (US) 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11118124-B1 Diamondoid fuels COXFA4, DCAF15, PC GRIN2D 3334/4885GRIN3B 3228/4885GRIN1 3694/4885
US-11203726-B1 Diamondoid fuels COXFA4, DCAF15, PC GRIN2D 3334/4885GRIN3B 3228/4885GRIN1 3694/4885
US-10710941-B1 Diamondoid fuels COXFA4, DCAF15, PC GRIN2D 3334/4885GRIN3B 3228/4885GRIN1 3694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.